Illinois General Assembly - Full Text of HB4576
Illinois General Assembly

Previous General Assemblies

Full Text of HB4576  99th General Assembly




HB4576 EnrolledLRB099 17088 MJP 41446 b

1    AN ACT concerning health.
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4    Section 1. Short title. This Act may be cited as the Rare
5Disease Commission Act.
6    Section 5. Definitions. As used in this Act, unless the
7context requires otherwise:
8    "Chairperson" means the Chairperson of the Rare Disease
10    "Commission" means the Rare Disease Commission.
11    "Rare disease" means a disease that affects less than
12200,000 people in the United States.
13    "Relative" means a spouse, parent, parent-in-law, sibling,
14sibling-in-law, child, child-in-law, grandparent, aunt, or
16    "Vice-Chairperson" means the Vice-Chairperson of the Rare
17Disease Commission.
18    Section 10. Commission created; membership.
19    (a) There is created the Rare Disease Commission to advise
20the State on issues pertaining to the care and treatment of
21individuals with rare diseases.
22    (b) The Commission shall be composed of 15 members:



HB4576 Enrolled- 2 -LRB099 17088 MJP 41446 b

1        (1) Eleven members shall be appointed by the Governor
2    from residents of the State whose position, knowledge, or
3    experience enables them to reasonably represent the
4    concerns, needs, and recommendations of those with rare
5    diseases, including physicians or health care providers
6    who treat patients with rare diseases. At a minimum, 5
7    members of the Commission shall be persons who either have
8    a rare disease or are a family member of a person living
9    with a rare disease. In making the appointments under this
10    paragraph (1), the Governor shall consider nominations
11    made by advocacy groups for rare diseases and
12    community-based organizations.
13        (2) One member of the Senate appointed by the President
14    of the Senate.
15        (3) One member of the Senate appointed by the Minority
16    Leader of the Senate.
17        (4) One member of the House of Representatives
18    appointed by the Speaker of the House of Representatives.
19        (5) One member of the House of Representatives
20    appointed by the Minority Leader of the House of
21    Representatives.
22    (c) The Chairperson of the Commission shall be elected from
23the Commission's membership by a simple majority vote of the
24total membership of the Commission. The Vice-Chairperson of the
25Commission shall be elected from the Commission's membership by
26a simple majority vote of the total membership of the



HB4576 Enrolled- 3 -LRB099 17088 MJP 41446 b

2    (d) The Governor, President of the Senate, Minority Leader
3of the Senate, Speaker of the House of Representatives, and
4Minority Leader of the House of Representatives shall make
5their initial appointments to the Commission by February 1,
7    (e) All members shall be appointed for terms of 3 years. No
8member shall serve more than 2 consecutive terms. A member
9shall serve until his or her successor is appointed and
11    (f) Vacancies in Commission membership shall be filled in
12the same manner as initial appointments. Appointments to fill
13vacancies occurring before the expiration of a term shall be
14for the remainder of the unexpired term.
15    (g) Total membership of the Commission consists of the
16number of members serving on the Commission not including any
17vacant positions. A quorum shall consist of a simple majority
18of total membership and shall be sufficient to conduct the
19transaction of business of the Commission, unless stipulated
20otherwise in the by-laws of the Commission.
21    (h) The Commission shall meet at least quarterly.
22    Section 15. Study; recommendations. The Commission shall
23make recommendations to the General Assembly, in the form of an
24annual report through 2020, regarding:
25        (1) the use of prescription drugs and innovative



HB4576 Enrolled- 4 -LRB099 17088 MJP 41446 b

1    therapies for children and adults with rare diseases, and
2    specific subpopulations of children or adults with rare
3    diseases, as appropriate, together with recommendations on
4    the ways in which this information should be used in
5    specific State programs that (A) provide assistance or
6    health care coverage to individuals with rare diseases or
7    broader populations that include individuals with rare
8    diseases, or (B) have responsibilities associated with
9    promoting the quality of care for individuals with rare
10    diseases or broader populations that include individuals
11    with rare diseases;
12        (2) legislation that could improve the care and
13    treatment of adults or children with rare diseases;
14        (3) in coordination with the Genetic and Metabolic
15    Diseases Advisory Committee, the screening of newborn
16    children for the presence of genetic disorders; and
17        (4) any other issues the Commission considers
18    appropriate.
19    The Commission shall submit its annual report to the
20General Assembly no later than December 31 of each year.
21    Section 20. Administrative support. The Department of
22Public Health shall provide administrative and other support to
23the Commission.
24    Section 90. Repeal. This Act is repealed on January 1,



HB4576 Enrolled- 5 -LRB099 17088 MJP 41446 b

2    Section 99. Effective date. This Act takes effect January
31, 2017.